TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB. March 31, 2000